Syneron Bio
PrivateLast Round
Series B
Mar 31, 2026
Total Funding Raised
$250M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Syneron Bio is a biotechnology company that develops next-generation macrocyclic peptide therapeutics for oncology and chronic diseases using its proprietary Synova™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syneron Bio Comparables
Compare Syneron Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Terray Therapeutics | 51% | |
| Recursion Pharmaceuticals | 49% | |
| Schrödinger | 49% |
Syneron Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 31, 2026 | ||||
| Series A | Dec 18, 2025 | ||||
| Pre Seed | Mar 13, 2023 |
Syneron Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KHK & Partners | Series A |
| BioTrack Capital | Series B |
| Hillhouse Investment | Series B, Series A |
| True Light Capital | Series B |
| 联想创投集团 (Lenovo Capital and Incubator Group) | Series B, Series A |
| 5Y Capital | Series B, Series A |
| Sinovation Ventures | Series B, Series A, Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
$150M round raised
- Dec 18, 2025
$100M round led by AstraZeneca and Pfizer
Syneron Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Syneron Bio's valuation, stock price, and market status.
Is Syneron Bio a public or private company?
Syneron Bio is a private company.
What is the current stock price of Syneron Bio?
Syneron Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Syneron Bio worth (valuation)?
Valuation information for Syneron Bio is not publicly available.
Can I buy Syneron Bio stock?
Syneron Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Syneron Bio's last funding round?
Syneron Bio's most recent funding round was Series B on March 31, 2026.
Who are the main investors in Syneron Bio?
Key investors in Syneron Bio include Sinovation Ventures, CDH VGC, Decheng Capital.
Will Syneron Bio IPO soon?
No public IPO plans have been announced for Syneron Bio.
How can I track Syneron Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Syneron Bio's secondary market activity and sign up for updates.